Johnson & Johnson (JNJ) Free Cash Flow Yield: 3.05%
Is Johnson & Johnson’s free cash flow yield high or low?
Johnson & Johnson's free cash flow yield of 3.05% is 30% below its 5-year average of 4.36%, near the low end of its 5-year range (3.05%–5.65%).
The free cash flow yield for Johnson & Johnson (JNJ) is 3.05% as of Wednesday, June 10, 2026. It is below its 12-month average by 18.88% (3.76%).
JNJ Free Cash Flow Yield Chart
JNJ Average Free Cash Flow Yield Chart
JNJ Current vs Average Free Cash Flow Yield Chart
JNJ Free Cash Flow Yield Metrics
FREE CASH FLOW YIELD
3.05%
FREE CASH FLOW YIELD AVG TTM
3.76%
FREE CASH FLOW YIELD AVG 3Y
4.32%
FREE CASH FLOW YIELD AVG 5Y
4.36%
FREE CASH FLOW YIELD AVG 10Y
4.60%
FREE CASH FLOW YIELD AVG 15Y
4.92%
FREE CASH FLOW YIELD AVG 20Y
5.45%
CURRENT VS TTM AVG
-18.88%
CURRENT VS 3Y AVG
-29.43%
CURRENT VS 5Y AVG
-30.12%
CURRENT VS 10Y AVG
-33.63%
CURRENT VS 15Y AVG
-37.98%
CURRENT VS 20Y AVG
-44.01%
JNJ Competitors' Free Cash Flow Yield
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Johnson & Johnson (JNJ) | $574.15B | 3.05% | 3.76% | 4.32% | 4.36% |
| Pfizer Inc. (PFE) | $146.36B | 6.45% | 7.35% | 5.93% | 7.34% |
| Merck & Co., Inc. (MRK) | $293.02B | 4.82% | 5.85% | 5.24% | 5.04% |
| AbbVie Inc. (ABBV) | $399.54B | 5.21% | 4.95% | 6.33% | 7.32% |
| Eli Lilly and Company (LLY) | $1.07T | 1.33% | 1.09% | 0.80% | 1.45% |
| Bristol-Myers Squibb Company (BMY) | $114.14B | 10.43% | 13.31% | 12.26% | 10.96% |
Yield Comparison
FCF Yield
3.05%
Earnings Yield
3.63%
Dividend Yield
2.20%
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
- Shows free cash flow after capital expenditures relative to market cap
- Can be compared with earnings yield and dividend yield
- Can be compared with the company's historical range
- Can be compared with peers that report positive free cash flow
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
Johnson & Johnson Free Cash Flow Yield Formula & Definition
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Johnson & Johnson Free Cash Flow Yield FAQ
- What is the free cash flow yield for Johnson & Johnson (JNJ)?
- The free cash flow yield for JNJ stock is 3.05%.
- Is Johnson & Johnson's free cash flow yield high or low?
- Johnson & Johnson's free cash flow yield of 3.05% is 30% below its 5-year average of 4.36%, near the low end of its 5-year range (3.05%–5.65%).
- What is the TTM average free cash flow yield for Johnson & Johnson (JNJ)?
- The TTM average free cash flow yield for JNJ stock is 3.76%.
- What is the 3Y average free cash flow yield for Johnson & Johnson (JNJ)?
- The 3Y average free cash flow yield for JNJ stock is 4.32%.
- What is the 5Y average free cash flow yield for Johnson & Johnson (JNJ)?
- The 5Y average free cash flow yield for JNJ stock is 4.36%.
- What is the 10Y average free cash flow yield for Johnson & Johnson (JNJ)?
- The 10Y average free cash flow yield for JNJ stock is 4.60%.
- What is the 15Y average free cash flow yield for Johnson & Johnson (JNJ)?
- The 15Y average free cash flow yield for JNJ stock is 4.92%.
- What is the 20Y average free cash flow yield for Johnson & Johnson (JNJ)?
- The 20Y average free cash flow yield for JNJ stock is 5.45%.
Johnson & Johnson Free Cash Flow Yield History
| DATE | FREE CASH FLOW YIELD |
|---|---|
| 2026-06-10 | 3.05% |
| 2026-06-09 | 3.07% |
| 2026-06-08 | 3.13% |
| 2026-06-05 | 3.13% |
| 2026-06-04 | 3.19% |
| 2026-06-03 | 3.26% |
| 2026-06-02 | 3.27% |
| 2026-06-01 | 3.26% |
| 2026-05-29 | 3.23% |
| 2026-05-28 | 3.15% |
| 2026-05-27 | 3.15% |
| 2026-05-26 | 3.16% |
| 2026-05-22 | 3.11% |
| 2026-05-21 | 3.14% |
| 2026-05-20 | 3.17% |
| 2026-05-19 | 3.16% |
| 2026-05-18 | 3.18% |
| 2026-05-15 | 3.21% |
| 2026-05-14 | 3.15% |
| 2026-05-13 | 3.16% |
| 2026-05-12 | 3.25% |
| 2026-05-11 | 3.29% |
| 2026-05-08 | 3.29% |
| 2026-05-07 | 3.27% |
| 2026-05-06 | 3.24% |
| 2026-05-05 | 3.23% |
| 2026-05-04 | 3.25% |
| 2026-05-01 | 3.20% |
| 2026-04-30 | 3.17% |
| 2026-04-29 | 3.20% |
| 2026-04-28 | 3.19% |
| 2026-04-27 | 3.23% |
| 2026-04-24 | 3.20% |
| 2026-04-23 | 3.16% |
| 2026-04-22 | 3.22% |
| 2026-04-21 | 3.57% |
| 2026-04-20 | 3.50% |
| 2026-04-17 | 3.45% |
| 2026-04-16 | 3.44% |
| 2026-04-15 | 3.38% |
| 2026-04-14 | 3.36% |
| 2026-04-13 | 3.39% |
| 2026-04-10 | 3.39% |
| 2026-04-09 | 3.35% |
| 2026-04-08 | 3.35% |
| 2026-04-07 | 3.39% |
| 2026-04-06 | 3.35% |
| 2026-04-02 | 3.32% |
| 2026-04-01 | 3.31% |
| 2026-03-31 | 3.30% |
| 2026-03-30 | 3.33% |
| 2026-03-27 | 3.36% |
| 2026-03-26 | 3.37% |
| 2026-03-25 | 3.37% |
| 2026-03-24 | 3.43% |
| 2026-03-23 | 3.43% |
| 2026-03-20 | 3.43% |
| 2026-03-19 | 3.40% |
| 2026-03-18 | 3.40% |
| 2026-03-17 | 3.39% |
| 2026-03-16 | 3.32% |
| 2026-03-13 | 3.34% |
| 2026-03-12 | 3.34% |
| 2026-03-11 | 3.32% |
| 2026-03-10 | 3.31% |
| 2026-03-09 | 3.33% |
| 2026-03-06 | 3.36% |
| 2026-03-05 | 3.37% |
| 2026-03-04 | 3.29% |
| 2026-03-03 | 3.27% |
| 2026-03-02 | 3.25% |
| 2026-02-27 | 3.25% |
| 2026-02-26 | 3.32% |
| 2026-02-25 | 3.29% |
| 2026-02-24 | 3.28% |
| 2026-02-23 | 3.29% |
| 2026-02-20 | 3.33% |
| 2026-02-19 | 3.27% |
| 2026-02-18 | 3.30% |
| 2026-02-17 | 3.32% |
| 2026-02-13 | 3.32% |
| 2026-02-12 | 3.30% |
| 2026-02-11 | 3.35% |
| 2026-02-10 | 3.29% |
| 2026-02-09 | 3.29% |
| 2026-02-06 | 3.27% |
| 2026-02-05 | 3.30% |
| 2026-02-04 | 3.35% |
| 2026-02-03 | 3.37% |
| 2026-02-02 | 3.40% |
| 2026-01-30 | 3.45% |
| 2026-01-29 | 3.45% |
| 2026-01-28 | 3.45% |
| 2026-01-27 | 3.50% |
| 2026-01-26 | 3.54% |
| 2026-01-23 | 3.57% |
| 2026-01-22 | 3.59% |
| 2026-01-21 | 3.60% |
| 2026-01-20 | 3.60% |
| 2026-01-16 | 3.59% |
| 2026-01-15 | 3.58% |
| 2026-01-14 | 3.59% |
| 2026-01-13 | 3.67% |
| 2026-01-12 | 3.74% |
| 2026-01-09 | 3.84% |
| 2026-01-08 | 3.82% |
| 2026-01-07 | 3.78% |
| 2026-01-06 | 3.83% |
| 2026-01-05 | 3.84% |
| 2026-01-02 | 3.79% |
| 2025-12-31 | 3.79% |
| 2025-12-30 | 3.79% |
| 2025-12-29 | 3.78% |
| 2025-12-26 | 3.78% |
| 2025-12-24 | 3.78% |
| 2025-12-23 | 3.82% |
| 2025-12-22 | 3.79% |
| 2025-12-19 | 3.80% |
| 2025-12-18 | 3.77% |
| 2025-12-17 | 3.73% |
| 2025-12-16 | 3.75% |
| 2025-12-15 | 3.67% |
| 2025-12-12 | 3.71% |
| 2025-12-11 | 3.74% |
| 2025-12-10 | 3.80% |
| 2025-12-09 | 3.93% |
| 2025-12-08 | 3.89% |
| 2025-12-05 | 3.89% |
| 2025-12-04 | 3.88% |
| 2025-12-03 | 3.82% |
| 2025-12-02 | 3.82% |
| 2025-12-01 | 3.82% |
| 2025-11-28 | 3.79% |
| 2025-11-26 | 3.78% |
| 2025-11-25 | 3.80% |
| 2025-11-24 | 3.81% |
| 2025-11-21 | 3.85% |
| 2025-11-20 | 3.87% |
| 2025-11-19 | 3.88% |
| 2025-11-18 | 3.92% |
| 2025-11-17 | 3.93% |
| 2025-11-14 | 4.01% |
| 2025-11-13 | 4.02% |
| 2025-11-12 | 4.04% |
| 2025-11-11 | 4.05% |
| 2025-11-10 | 4.17% |
| 2025-11-07 | 4.21% |
| 2025-11-06 | 4.20% |
| 2025-11-05 | 4.22% |
| 2025-11-04 | 4.20% |
| 2025-11-03 | 4.21% |
| 2025-10-31 | 4.16% |
| 2025-10-30 | 4.15% |
| 2025-10-29 | 4.21% |
| 2025-10-28 | 4.20% |
| 2025-10-27 | 4.13% |
| 2025-10-24 | 4.12% |
| 2025-10-23 | 4.08% |
| 2025-10-22 | 4.07% |
| 2025-10-21 | 3.53% |
| 2025-10-20 | 3.50% |
| 2025-10-17 | 3.51% |
| 2025-10-16 | 3.53% |
| 2025-10-15 | 3.55% |
| 2025-10-14 | 3.55% |
| 2025-10-13 | 3.55% |
| 2025-10-10 | 3.55% |
| 2025-10-09 | 3.55% |
| 2025-10-08 | 3.57% |
| 2025-10-07 | 3.59% |
| 2025-10-06 | 3.60% |
| 2025-10-03 | 3.59% |
| 2025-10-02 | 3.64% |
| 2025-10-01 | 3.64% |
| 2025-09-30 | 3.65% |
| 2025-09-29 | 3.73% |
| 2025-09-26 | 3.77% |
| 2025-09-25 | 3.81% |
| 2025-09-24 | 3.84% |
| 2025-09-23 | 3.84% |
| 2025-09-22 | 3.89% |
| 2025-09-19 | 3.85% |
| 2025-09-18 | 3.89% |
| 2025-09-17 | 3.83% |
| 2025-09-16 | 3.84% |
| 2025-09-15 | 3.82% |
| 2025-09-12 | 3.81% |
| 2025-09-11 | 3.80% |
| 2025-09-10 | 3.86% |
| 2025-09-09 | 3.83% |
| 2025-09-08 | 3.81% |
| 2025-09-05 | 3.80% |
| 2025-09-04 | 3.79% |
| 2025-09-03 | 3.81% |
| 2025-09-02 | 3.81% |
| 2025-08-29 | 3.83% |
| 2025-08-28 | 3.86% |
| 2025-08-27 | 3.83% |
| 2025-08-26 | 3.84% |
| 2025-08-25 | 3.80% |
| 2025-08-22 | 3.78% |
| 2025-08-21 | 3.79% |
| 2025-08-20 | 3.79% |
| 2025-08-19 | 3.81% |
| 2025-08-18 | 3.85% |
| 2025-08-15 | 3.84% |
| 2025-08-14 | 3.88% |
| 2025-08-13 | 3.89% |
| 2025-08-12 | 3.92% |
| 2025-08-11 | 3.90% |
| 2025-08-08 | 3.91% |
| 2025-08-07 | 3.95% |
| 2025-08-06 | 3.97% |
| 2025-08-05 | 3.97% |
| 2025-08-04 | 3.96% |
| 2025-08-01 | 4.05% |
| 2025-07-31 | 4.12% |
| 2025-07-30 | 4.05% |
| 2025-07-29 | 4.03% |
| 2025-07-28 | 4.08% |
| 2025-07-25 | 4.03% |
| 2025-07-24 | 4.00% |
| 2025-07-23 | 4.53% |
| 2025-07-22 | 4.56% |
| 2025-07-21 | 4.66% |
| 2025-07-18 | 4.68% |
| 2025-07-17 | 4.70% |
| 2025-07-16 | 4.65% |
| 2025-07-15 | 4.94% |
| 2025-07-14 | 4.89% |
| 2025-07-11 | 4.89% |
| 2025-07-10 | 4.86% |
| 2025-07-09 | 4.90% |
| 2025-07-08 | 4.92% |
| 2025-07-07 | 4.94% |
| 2025-07-03 | 4.91% |
| 2025-07-02 | 4.93% |
| 2025-07-01 | 4.91% |
| 2025-06-30 | 5.02% |
| 2025-06-27 | 5.03% |
| 2025-06-26 | 5.04% |
| 2025-06-25 | 5.03% |
| 2025-06-24 | 5.04% |
| 2025-06-23 | 5.06% |
| 2025-06-20 | 5.12% |
| 2025-06-18 | 5.08% |
| 2025-06-17 | 5.03% |
| 2025-06-16 | 4.94% |
| 2025-06-13 | 4.88% |
| 2025-06-12 | 4.89% |
| 2025-06-11 | 4.94% |
| 2025-06-10 | 4.90% |
| 2025-06-09 | 4.94% |
| 2025-06-06 | 4.94% |
| 2025-06-05 | 4.99% |
| 2025-06-04 | 5.00% |
| 2025-06-03 | 4.96% |
| 2025-06-02 | 4.93% |
| 2025-05-30 | 4.94% |
| 2025-05-29 | 4.99% |
Showing the most recent 260 of 5,031 data points. The chart above shows the full history.
About Johnson & Johnson
Johnson & Johnson (JNJ) operates globally, engaging in the research, development, production, and distribution of a diverse range of healthcare products. In a pivotal strategic move in 2023, the company divested its Consumer Health division, establishing it as the independent entity Kenvue Inc. This separation was implemented to allow J&J to sharpen its focus on higher-growth, innovation-led areas. Consequently, well-known consumer brands like TYLENOL, LISTERINE, and BAND-AID are now part of Kenvue's portfolio. Johnson & Johnson's current operations are centered around two primary divisions: Innovative Medicine and MedTech. The Innovative Medicine segment, formerly known as Pharmaceuticals, specializes in prescription drugs designed to treat complex ailments such as rheumatoid arthritis, various forms of cancer, HIV/AIDS, and neurodegenerative disorders. Its MedTech division, encompassing Medical Devices, delivers cutting-edge technological solutions, including electrophysiology equipment, neurovascular care products, orthopaedic implants for hips, knees, and spine, advanced surgical technologies, and ACUVUE brand disposable contact lenses. These two streamlined segments primarily cater to a client base comprising hospitals, medical professionals, wholesale distributors, and retail outlets. From its headquarters in New Brunswick, New Jersey, Johnson & Johnson continues to uphold its enduring mission of advancing human health, a commitment it has maintained since its founding in 1886.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Joaquin Duato